Source: Eur Respir J 2014; 43: 331-333



Rating:

Share or cite this content

Citations should be made in the following way:
Woodhead Mark. Pneumococcal serotypes and respiratory failure: soil or seed?. Eur Respir J 2014; 43: 331-333

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes Source: Eur Respir J 2014; 43: 545-553 Year: 2013 Effectiveness of 23-valent pneumococcal polysaccharide vaccine in preventing lower respiratory tract infections complicating chronic respiratory failure Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Haemophilus influenza related respiratory infections and hospital re-admissions Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response Source: Eur Respir J 2002; 20: Suppl. 38, 472s Year: 2002 Pneumococcal and Hemophilus vaccination: real world effectivity including pulmonary diseases Source: International Congress 2019 – Vaccines against respiratory infections Year: 2019 Differentiation between pneumococcal and viral pneumonia in children: what is the best combination of nonspecific markers? Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001 Lower respiratory tract infections in the European GRACE primary care network: Bacterial causes or do viruses also matter? Source: Annual Congress 2011 - Appropriate use of antibiotics in respiratory infections in Europe (the GRACE project) Year: 2011 Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Should pneumococcal vaccines be used to prevent LRTI? Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 Investigation of factors associated with result of pneumococcal urinary antigen in the microbiological investigation of pneumococcal lower respiratory infections Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Antibiotic resistance genotype trend and association with host clinical characteristics in respiratory isolates of streptococcus pneumoniae Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia Source: Eur Respir J 2010; 36: 1073-1079 Year: 2010 Characteristics of patients with serotype 5 pneumococcal pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Evolutionary trend of invasive pneumococcal disease according to serotypes Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Detection of Hemophilus Influenzae in children with respiratory syncytial virus and rhinovirus lower respiratory tract infection Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015 Sporadic and epidemic community legionellosis: two faces of the same illness Source: Eur Respir J 2007; 29: 138-142 Year: 2007